ArticleMolecular cancer therapeutics2024

Targeting NANOG and FAK via Cx26-derived Cell-penetrating Peptides in Triple-negative Breast Cancer.

Erin E Mulkearns-Hubert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.